[
  {
    "id": "aemt-dex-q-001",
    "scope": ["AEMT"],
    "medicationId": "aemt-dex-001",
    "medication": "Dextrose",
    "questionType": "multiple-choice",
    "stem": "Which blood glucose value indicates the need for IV dextrose?",
    "choices": [
      "110 mg/dL",
      "85 mg/dL",
      "58 mg/dL",
      "140 mg/dL"
    ],
    "correctAnswer": "58 mg/dL",
    "rationale": "Hypoglycemia requires rapid glucose correction.",
    "clinicalPearl": "Always confirm hypoglycemia when possible."
  },
  {
    "id": "aemt-dex-q-002",
    "scope": ["AEMT"],
    "medicationId": "aemt-dex-001",
    "medication": "Dextrose",
    "questionType": "multiple-choice",
    "stem": "Why is D10 often preferred over D50 in pediatric patients?",
    "choices": [
      "Longer shelf life",
      "Lower risk of extravasation injury",
      "Faster onset",
      "Less need for IV access"
    ],
    "correctAnswer": "Lower risk of extravasation injury",
    "rationale": "Lower concentration reduces tissue damage risk.",
    "clinicalPearl": "Hypertonic solutions can cause severe tissue necrosis."
  },
  {
    "id": "aemt-dex-q-003",
    "scope": ["AEMT"],
    "medicationId": "aemt-dex-001",
    "medication": "Dextrose",
    "questionType": "multiple-choice",
    "stem": "Which assessment is most important after dextrose administration?",
    "choices": [
      "Heart rate",
      "Blood glucose reassessment",
      "Blood pressure",
      "Skin temperature"
    ],
    "correctAnswer": "Blood glucose reassessment",
    "rationale": "Treatment effectiveness must be confirmed.",
    "clinicalPearl": "Treat, reassess, and prevent recurrence."
  },

  {
    "id": "aemt-nalox-q-001",
    "scope": ["AEMT"],
    "medicationId": "aemt-nalox-001",
    "medication": "Naloxone",
    "questionType": "multiple-choice",
    "stem": "Naloxone administration primarily improves which patient condition?",
    "choices": [
      "Hypotension",
      "Respiratory depression",
      "Chest pain",
      "Hypoglycemia"
    ],
    "correctAnswer": "Respiratory depression",
    "rationale": "Naloxone reverses opioid-induced respiratory depression.",
    "clinicalPearl": "Airway and ventilation always come first."
  },
  {
    "id": "aemt-nalox-q-002",
    "scope": ["AEMT"],
    "medicationId": "aemt-nalox-001",
    "medication": "Naloxone",
    "questionType": "multiple-choice",
    "stem": "Which response is most likely after naloxone administration?",
    "choices": [
      "Gradual sedation",
      "Improved respirations with agitation",
      "Immediate pain relief",
      "Decreased heart rate"
    ],
    "correctAnswer": "Improved respirations with agitation",
    "rationale": "Rapid opioid reversal may cause acute withdrawal.",
    "clinicalPearl": "Expect agitation—protect yourself and the patient."
  },
  {
    "id": "aemt-nalox-q-003",
    "scope": ["AEMT"],
    "medicationId": "aemt-nalox-001",
    "medication": "Naloxone",
    "questionType": "multiple-choice",
    "stem": "Why must patients receiving naloxone be closely monitored?",
    "choices": [
      "Naloxone causes hypoglycemia",
      "Naloxone has a shorter duration than many opioids",
      "Naloxone causes bradycardia",
      "Naloxone permanently blocks opioid receptors"
    ],
    "correctAnswer": "Naloxone has a shorter duration than many opioids",
    "rationale": "Re-narcotization can occur after naloxone wears off.",
    "clinicalPearl": "Repeat dosing may be required."
  },
  {
    "id": "aemt-dex-q-001",
    "scope": ["AEMT"],
    "medicationId": "aemt-dex-001",
    "medication": "Dextrose",
    "questionType": "multiple-choice",
    "stem": "Which blood glucose value indicates the need for IV dextrose?",
    "choices": [
      "110 mg/dL",
      "85 mg/dL",
      "58 mg/dL",
      "140 mg/dL"
    ],
    "correctAnswer": "58 mg/dL",
    "rationale": "Hypoglycemia requires rapid glucose correction.",
    "clinicalPearl": "Always confirm hypoglycemia when possible."
  },
  {
    "id": "aemt-dex-q-002",
    "scope": ["AEMT"],
    "medicationId": "aemt-dex-001",
    "medication": "Dextrose",
    "questionType": "multiple-choice",
    "stem": "Why is D10 often preferred over D50 in pediatric patients?",
    "choices": [
      "Longer shelf life",
      "Lower risk of extravasation injury",
      "Faster onset",
      "Less need for IV access"
    ],
    "correctAnswer": "Lower risk of extravasation injury",
    "rationale": "Lower concentration reduces tissue damage risk.",
    "clinicalPearl": "Hypertonic solutions can cause severe tissue necrosis."
  },
  {
    "id": "aemt-dex-q-003",
    "scope": ["AEMT"],
    "medicationId": "aemt-dex-001",
    "medication": "Dextrose",
    "questionType": "multiple-choice",
    "stem": "Which assessment is most important after dextrose administration?",
    "choices": [
      "Heart rate",
      "Blood glucose reassessment",
      "Blood pressure",
      "Skin temperature"
    ],
    "correctAnswer": "Blood glucose reassessment",
    "rationale": "Treatment effectiveness must be confirmed.",
    "clinicalPearl": "Treat, reassess, and prevent recurrence."
  },
  {
    "id": "aemt-nalox-q-001",
    "scope": ["AEMT"],
    "medicationId": "aemt-nalox-001",
    "medication": "Naloxone",
    "questionType": "multiple-choice",
    "stem": "Naloxone administration primarily improves which patient condition?",
    "choices": [
      "Hypotension",
      "Respiratory depression",
      "Chest pain",
      "Hypoglycemia"
    ],
    "correctAnswer": "Respiratory depression",
    "rationale": "Naloxone reverses opioid-induced respiratory depression.",
    "clinicalPearl": "Airway and ventilation always come first."
  },
  {
    "id": "aemt-nalox-q-002",
    "scope": ["AEMT"],
    "medicationId": "aemt-nalox-001",
    "medication": "Naloxone",
    "questionType": "multiple-choice",
    "stem": "Which response is most likely after naloxone administration?",
    "choices": [
      "Gradual sedation",
      "Improved respirations with agitation",
      "Immediate pain relief",
      "Decreased heart rate"
    ],
    "correctAnswer": "Improved respirations with agitation",
    "rationale": "Rapid opioid reversal may cause acute withdrawal.",
    "clinicalPearl": "Expect agitation—protect yourself and the patient."
  },
  {
    "id": "aemt-nalox-q-003",
    "scope": ["AEMT"],
    "medicationId": "aemt-nalox-001",
    "medication": "Naloxone",
    "questionType": "multiple-choice",
    "stem": "Why must patients receiving naloxone be closely monitored?",
    "choices": [
      "Naloxone causes hypoglycemia",
      "Naloxone has a shorter duration than many opioids",
      "Naloxone causes bradycardia",
      "Naloxone permanently blocks opioid receptors"
    ],
    "correctAnswer": "Naloxone has a shorter duration than many opioids",
    "rationale": "Re-narcotization can occur after naloxone wears off.",
    "clinicalPearl": "Repeat dosing may be required."
  },
  {
    "id": "aemt-ns-q-001",
    "scope": ["AEMT"],
    "medicationId": "aemt-ns-001",
    "medication": "Normal Saline",
    "questionType": "multiple-choice",
    "stem": "Normal saline improves perfusion primarily through which mechanism?",
    "choices": [
      "Increasing cardiac contractility",
      "Expanding intravascular volume",
      "Causing vasodilation",
      "Reducing afterload"
    ],
    "correctAnswer": "Expanding intravascular volume",
    "rationale": "Normal saline increases circulating volume, improving preload and perfusion.",
    "clinicalPearl": "Crystalloids restore volume but do not carry oxygen."
  },
  {
    "id": "aemt-ns-q-002",
    "scope": ["AEMT"],
    "medicationId": "aemt-ns-001",
    "medication": "Normal Saline",
    "questionType": "multiple-choice",
    "stem": "Which patient is at greatest risk for complications from large-volume normal saline boluses?",
    "choices": [
      "Young trauma patient",
      "Patient with heart failure",
      "Dehydrated athlete",
      "Febrile pediatric patient"
    ],
    "correctAnswer": "Patient with heart failure",
    "rationale": "Fluid overload can worsen pulmonary edema in heart failure.",
    "clinicalPearl": "Always reassess lung sounds during fluid resuscitation."
  },
  {
    "id": "aemt-ns-q-003",
    "scope": ["AEMT"],
    "medicationId": "aemt-ns-001",
    "medication": "Normal Saline",
    "questionType": "multiple-choice",
    "stem": "What is the standard initial adult bolus dose of normal saline for hypovolemia?",
    "choices": [
      "100–250 mL",
      "250–500 mL",
      "500–1000 mL",
      "1500–2000 mL"
    ],
    "correctAnswer": "500–1000 mL",
    "rationale": "Initial adult fluid boluses are typically 500–1000 mL per protocol.",
    "clinicalPearl": "Bolus, reassess, repeat if indicated."
  },

  {
    "id": "aemt-apap-q-001",
    "scope": ["AEMT"],
    "medicationId": "aemt-apap-001",
    "medication": "Acetaminophen",
    "questionType": "multiple-choice",
    "stem": "Acetaminophen reduces fever primarily by acting where?",
    "choices": [
      "Peripheral nerves",
      "Hypothalamus",
      "Platelets",
      "Adrenal cortex"
    ],
    "correctAnswer": "Hypothalamus",
    "rationale": "Acetaminophen acts centrally to reduce the hypothalamic set point.",
    "clinicalPearl": "It is not an anti-inflammatory medication."
  },
  {
    "id": "aemt-apap-q-002",
    "scope": ["AEMT"],
    "medicationId": "aemt-apap-001",
    "medication": "Acetaminophen",
    "questionType": "multiple-choice",
    "stem": "Which condition contraindicates acetaminophen use?",
    "choices": [
      "Renal disease",
      "Peptic ulcer disease",
      "Severe liver disease",
      "Hypertension"
    ],
    "correctAnswer": "Severe liver disease",
    "rationale": "Acetaminophen is hepatotoxic at high doses or in liver disease.",
    "clinicalPearl": "Always consider cumulative daily dose."
  },
  {
    "id": "aemt-apap-q-003",
    "scope": ["AEMT"],
    "medicationId": "aemt-apap-001",
    "medication": "Acetaminophen",
    "questionType": "multiple-choice",
    "stem": "Which is an appropriate pediatric dose of acetaminophen?",
    "choices": [
      "5 mg/kg",
      "10–15 mg/kg",
      "25 mg/kg",
      "50 mg/kg"
    ],
    "correctAnswer": "10–15 mg/kg",
    "rationale": "Standard pediatric dosing is weight based at 10–15 mg/kg.",
    "clinicalPearl": "Weight-based dosing prevents toxicity."
  },

  {
    "id": "aemt-ibu-q-001",
    "scope": ["AEMT"],
    "medicationId": "aemt-ibu-001",
    "medication": "Ibuprofen",
    "questionType": "multiple-choice",
    "stem": "Ibuprofen reduces pain primarily by inhibiting which enzyme?",
    "choices": [
      "Lipoxygenase",
      "Cyclooxygenase",
      "Acetylcholinesterase",
      "Monoamine oxidase"
    ],
    "correctAnswer": "Cyclooxygenase",
    "rationale": "COX inhibition decreases prostaglandin production.",
    "clinicalPearl": "Prostaglandins mediate pain, fever, and inflammation."
  },
  {
    "id": "aemt-ibu-q-002",
    "scope": ["AEMT"],
    "medicationId": "aemt-ibu-001",
    "medication": "Ibuprofen",
    "questionType": "multiple-choice",
    "stem": "Which patient should NOT receive ibuprofen?",
    "choices": [
      "Fever with dehydration",
      "History of renal disease",
      "Musculoskeletal injury",
      "Mild headache"
    ],
    "correctAnswer": "History of renal disease",
    "rationale": "NSAIDs can worsen renal perfusion.",
    "clinicalPearl": "NSAIDs affect renal blood flow."
  },
  {
    "id": "aemt-ibu-q-003",
    "scope": ["AEMT"],
    "medicationId": "aemt-ibu-001",
    "medication": "Ibuprofen",
    "questionType": "multiple-choice",
    "stem": "What is a common adverse effect of ibuprofen?",
    "choices": [
      "Hypoglycemia",
      "GI irritation",
      "Bradycardia",
      "Respiratory depression"
    ],
    "correctAnswer": "GI irritation",
    "rationale": "NSAIDs increase gastric irritation and bleeding risk.",
    "clinicalPearl": "Consider GI history before NSAID use."
  },

  {
    "id": "aemt-char-q-001",
    "scope": ["AEMT"],
    "medicationId": "aemt-char-001",
    "medication": "Activated Charcoal",
    "questionType": "multiple-choice",
    "stem": "Activated charcoal works by which mechanism?",
    "choices": [
      "Neutralizing stomach acid",
      "Binding toxins in the GI tract",
      "Inducing emesis",
      "Increasing renal excretion"
    ],
    "correctAnswer": "Binding toxins in the GI tract",
    "rationale": "Charcoal adsorbs toxins, limiting absorption.",
    "clinicalPearl": "It does not work on all poisons."
  },
  {
    "id": "aemt-char-q-002",
    "scope": ["AEMT"],
    "medicationId": "aemt-char-001",
    "medication": "Activated Charcoal",
    "questionType": "multiple-choice",
    "stem": "Which ingestion is a contraindication to activated charcoal?",
    "choices": [
      "Acetaminophen",
      "Tricyclic antidepressants",
      "Caustic substances",
      "Aspirin"
    ],
    "correctAnswer": "Caustic substances",
    "rationale": "Charcoal does not bind caustics and increases aspiration risk.",
    "clinicalPearl": "Never give charcoal without airway protection."
  },
  {
    "id": "aemt-char-q-003",
    "scope": ["AEMT"],
    "medicationId": "aemt-char-001",
    "medication": "Activated Charcoal",
    "questionType": "multiple-choice",
    "stem": "Which patient must NOT receive activated charcoal?",
    "choices": [
      "Alert adult",
      "Patient with intact gag reflex",
      "Patient with decreased LOC",
      "Cooperative pediatric patient"
    ],
    "correctAnswer": "Patient with decreased LOC",
    "rationale": "Aspiration risk is high without airway protection.",
    "clinicalPearl": "Airway comes before antidotes."
  },

  {
    "id": "aemt-duoneb-q-001",
    "scope": ["AEMT"],
    "medicationId": "aemt-duoneb-001",
    "medication": "Albuterol / Ipratropium (DuoNeb)",
    "questionType": "multiple-choice",
    "stem": "DuoNeb combines which two pharmacologic actions?",
    "choices": [
      "Alpha agonist and steroid",
      "Beta-2 agonist and anticholinergic",
      "Steroid and antihistamine",
      "Beta blocker and bronchodilator"
    ],
    "correctAnswer": "Beta-2 agonist and anticholinergic",
    "rationale": "Albuterol and ipratropium provide dual bronchodilation.",
    "clinicalPearl": "Combination therapy improves airflow."
  },
  {
    "id": "aemt-duoneb-q-002",
    "scope": ["AEMT"],
    "medicationId": "aemt-duoneb-001",
    "medication": "Albuterol / Ipratropium (DuoNeb)",
    "questionType": "multiple-choice",
    "stem": "Which patient would benefit most from DuoNeb?",
    "choices": [
      "Pulmonary edema",
      "CHF exacerbation",
      "COPD exacerbation",
      "Pneumothorax"
    ],
    "correctAnswer": "COPD exacerbation",
    "rationale": "Combination bronchodilators are first-line in COPD flares.",
    "clinicalPearl": "COPD often requires dual therapy."
  },
  {
    "id": "aemt-duoneb-q-003",
    "scope": ["AEMT"],
    "medicationId": "aemt-duoneb-001",
    "medication": "Albuterol / Ipratropium (DuoNeb)",
    "questionType": "multiple-choice",
    "stem": "Which side effect is most associated with albuterol?",
    "choices": [
      "Bradycardia",
      "Tremors and tachycardia",
      "Respiratory depression",
      "Hypotension"
    ],
    "correctAnswer": "Tremors and tachycardia",
    "rationale": "Beta-2 stimulation commonly causes tremors and tachycardia.",
    "clinicalPearl": "Monitor heart rate during repeated treatments."
  },
  {
    "id": "aemt-ns-q-004",
    "scope": ["AEMT"],
    "medicationId": "aemt-ns-001",
    "medication": "Normal Saline",
    "questionType": "multiple-choice",
    "stem": "Which assessment finding suggests a positive response to a normal saline bolus?",
    "choices": [
      "Decreased lung sounds",
      "Improved blood pressure",
      "Increased temperature",
      "Worsening jugular venous distention"
    ],
    "correctAnswer": "Improved blood pressure",
    "rationale": "Improved blood pressure indicates increased circulating volume and perfusion.",
    "clinicalPearl": "Vital signs guide fluid resuscitation effectiveness."
  },
  {
    "id": "aemt-ns-q-005",
    "scope": ["AEMT"],
    "medicationId": "aemt-ns-001",
    "medication": "Normal Saline",
    "questionType": "multiple-choice",
    "stem": "Why is normal saline considered an isotonic solution?",
    "choices": [
      "It draws fluid into cells",
      "It pulls fluid out of cells",
      "It has the same osmolarity as plasma",
      "It contains glucose"
    ],
    "correctAnswer": "It has the same osmolarity as plasma",
    "rationale": "Isotonic fluids do not cause significant fluid shifts between compartments.",
    "clinicalPearl": "Isotonic fluids primarily expand intravascular volume."
  },

  {
    "id": "aemt-apap-q-004",
    "scope": ["AEMT"],
    "medicationId": "aemt-apap-001",
    "medication": "Acetaminophen",
    "questionType": "multiple-choice",
    "stem": "Which symptom may indicate acetaminophen toxicity?",
    "choices": [
      "Early nausea and vomiting",
      "Bradycardia",
      "Bronchospasm",
      "Hypertension"
    ],
    "correctAnswer": "Early nausea and vomiting",
    "rationale": "Early toxicity often presents with GI symptoms before liver injury is evident.",
    "clinicalPearl": "Liver damage may be delayed despite early mild symptoms."
  },
  {
    "id": "aemt-apap-q-005",
    "scope": ["AEMT"],
    "medicationId": "aemt-apap-001",
    "medication": "Acetaminophen",
    "questionType": "multiple-choice",
    "stem": "Which action helps reduce the risk of acetaminophen overdose?",
    "choices": [
      "Combining with NSAIDs",
      "Using maximum adult doses routinely",
      "Tracking total daily intake",
      "Administering with food"
    ],
    "correctAnswer": "Tracking total daily intake",
    "rationale": "Toxicity is related to cumulative dosing over 24 hours.",
    "clinicalPearl": "Many OTC products contain acetaminophen."
  },

  {
    "id": "aemt-ibu-q-004",
    "scope": ["AEMT"],
    "medicationId": "aemt-ibu-001",
    "medication": "Ibuprofen",
    "questionType": "multiple-choice",
    "stem": "Why should ibuprofen be used cautiously in dehydrated patients?",
    "choices": [
      "It causes hypoglycemia",
      "It increases bleeding time",
      "It can reduce renal perfusion",
      "It suppresses respiration"
    ],
    "correctAnswer": "It can reduce renal perfusion",
    "rationale": "NSAIDs inhibit prostaglandins that support renal blood flow.",
    "clinicalPearl": "Hydration status matters when giving NSAIDs."
  },
  {
    "id": "aemt-ibu-q-005",
    "scope": ["AEMT"],
    "medicationId": "aemt-ibu-001",
    "medication": "Ibuprofen",
    "questionType": "multiple-choice",
    "stem": "Ibuprofen provides analgesia primarily through which additional effect?",
    "choices": [
      "Sedation",
      "Anti-inflammatory action",
      "Muscle relaxation",
      "Vasoconstriction"
    ],
    "correctAnswer": "Anti-inflammatory action",
    "rationale": "Reducing inflammation decreases pain at the injury site.",
    "clinicalPearl": "Inflammation is a major contributor to pain."
  },

  {
    "id": "aemt-char-q-004",
    "scope": ["AEMT"],
    "medicationId": "aemt-char-001",
    "medication": "Activated Charcoal",
    "questionType": "multiple-choice",
    "stem": "Activated charcoal is most effective when administered within what time frame?",
    "choices": [
      "Immediately regardless of time",
      "Within 1–2 hours of ingestion",
      "After symptoms appear",
      "Only after vomiting stops"
    ],
    "correctAnswer": "Within 1–2 hours of ingestion",
    "rationale": "Earlier administration limits toxin absorption.",
    "clinicalPearl": "Timing is critical for charcoal effectiveness."
  },
  {
    "id": "aemt-char-q-005",
    "scope": ["AEMT"],
    "medicationId": "aemt-char-001",
    "medication": "Activated Charcoal",
    "questionType": "multiple-choice",
    "stem": "Why is activated charcoal contraindicated in patients who have ingested hydrocarbons?",
    "choices": [
      "It neutralizes the toxin",
      "It increases absorption",
      "Aspiration risk outweighs benefit",
      "It causes hypotension"
    ],
    "correctAnswer": "Aspiration risk outweighs benefit",
    "rationale": "Hydrocarbons increase aspiration risk without effective adsorption.",
    "clinicalPearl": "Risk–benefit assessment guides charcoal use."
  },

  {
    "id": "aemt-duoneb-q-004",
    "scope": ["AEMT"],
    "medicationId": "aemt-duoneb-001",
    "medication": "Albuterol / Ipratropium (DuoNeb)",
    "questionType": "multiple-choice",
    "stem": "Which finding indicates effective DuoNeb treatment?",
    "choices": [
      "Decreased respiratory rate and wheezing",
      "Increased crackles",
      "Decreased oxygen saturation",
      "Worsening accessory muscle use"
    ],
    "correctAnswer": "Decreased respiratory rate and wheezing",
    "rationale": "Improved airflow reduces work of breathing.",
    "clinicalPearl": "Clinical improvement matters more than lung sounds alone."
  },
  {
    "id": "aemt-duoneb-q-005",
    "scope": ["AEMT"],
    "medicationId": "aemt-duoneb-001",
    "medication": "Albuterol / Ipratropium (DuoNeb)",
    "questionType": "multiple-choice",
    "stem": "Which mechanism explains ipratropium’s bronchodilating effect?",
    "choices": [
      "Beta-2 stimulation",
      "Histamine blockade",
      "Parasympathetic inhibition",
      "Corticosteroid action"
    ],
    "correctAnswer": "Parasympathetic inhibition",
    "rationale": "Ipratropium blocks muscarinic receptors, reducing bronchoconstriction.",
    "clinicalPearl": "Different pathways provide additive bronchodilation."
  },

  {
    "id": "aemt-glucose-q-001",
    "scope": ["AEMT"],
    "medicationId": "aemt-glucose-oral-001",
    "medication": "Oral Glucose",
    "questionType": "multiple-choice",
    "stem": "Which patient is the best candidate for oral glucose?",
    "choices": [
      "Unresponsive diabetic",
      "Patient with vomiting",
      "Alert patient with low blood glucose",
      "Patient with airway compromise"
    ],
    "correctAnswer": "Alert patient with low blood glucose",
    "rationale": "Oral glucose requires intact mental status and swallowing ability.",
    "clinicalPearl": "Never give oral meds without airway control."
  },
  {
    "id": "aemt-glucose-q-002",
    "scope": ["AEMT"],
    "medicationId": "aemt-glucose-oral-001",
    "medication": "Oral Glucose",
    "questionType": "multiple-choice",
    "stem": "What is the primary risk of administering oral glucose to an altered patient?",
    "choices": [
      "Hyperglycemia",
      "Aspiration",
      "Hypotension",
      "Bradycardia"
    ],
    "correctAnswer": "Aspiration",
    "rationale": "Altered mental status increases aspiration risk.",
    "clinicalPearl": "Airway assessment comes first."
  },

  {
    "id": "aemt-nalox-q-004",
    "scope": ["AEMT"],
    "medicationId": "aemt-nalox-001",
    "medication": "Naloxone",
    "questionType": "multiple-choice",
    "stem": "Naloxone has little to no effect in overdoses involving which substance?",
    "choices": [
      "Heroin",
      "Oxycodone",
      "Benzodiazepines",
      "Morphine"
    ],
    "correctAnswer": "Benzodiazepines",
    "rationale": "Naloxone only reverses opioid effects.",
    "clinicalPearl": "Not all overdoses respond to naloxone."
  },
  {
    "id": "aemt-nalox-q-005",
    "scope": ["AEMT"],
    "medicationId": "aemt-nalox-001",
    "medication": "Naloxone",
    "questionType": "multiple-choice",
    "stem": "What is the primary goal of naloxone administration in the field?",
    "choices": [
      "Complete consciousness",
      "Pain relief",
      "Adequate spontaneous respirations",
      "Sedation"
    ],
    "correctAnswer": "Adequate spontaneous respirations",
    "rationale": "The goal is ventilation, not full reversal.",
    "clinicalPearl": "Titrate naloxone to breathing, not alertness."
  },
  {
    "id": "aemt-ns-scn-001",
    "scope": ["AEMT"],
    "medicationId": "aemt-ns-001",
    "medication": "Normal Saline",
    "questionType": "multiple-choice",
    "stem": "You are treating a 72-year-old patient with vomiting and diarrhea. BP is 88/56, HR 118, lungs are clear. Which intervention is most appropriate?",
    "choices": [
      "Administer oral fluids",
      "Initiate a 500–1000 mL normal saline bolus",
      "Administer acetaminophen",
      "Withhold fluids due to age"
    ],
    "correctAnswer": "Initiate a 500–1000 mL normal saline bolus",
    "rationale": "Signs of hypovolemia with hypotension warrant IV fluid resuscitation.",
    "clinicalPearl": "Treat the shock state, not the age."
  },
  {
    "id": "aemt-ns-scn-002",
    "scope": ["AEMT"],
    "medicationId": "aemt-ns-001",
    "medication": "Normal Saline",
    "questionType": "multiple-choice",
    "stem": "After administering a normal saline bolus, which finding would require you to slow or stop fluids?",
    "choices": [
      "Improving blood pressure",
      "Crackles developing in lung bases",
      "Heart rate decreasing",
      "Improved mental status"
    ],
    "correctAnswer": "Crackles developing in lung bases",
    "rationale": "New crackles suggest fluid overload or pulmonary edema.",
    "clinicalPearl": "Fluids are medications — reassess often."
  },

  {
    "id": "aemt-apap-scn-001",
    "scope": ["AEMT"],
    "medicationId": "aemt-apap-001",
    "medication": "Acetaminophen",
    "questionType": "multiple-choice",
    "stem": "A 6-year-old patient weighs 20 kg and has a fever of 102.8°F. What is the appropriate acetaminophen dose?",
    "choices": [
      "100 mg",
      "200 mg",
      "300 mg",
      "600 mg"
    ],
    "correctAnswer": "300 mg",
    "rationale": "Pediatric dosing is 10–15 mg/kg (20 kg × 15 mg = 300 mg).",
    "clinicalPearl": "Always calculate pediatric doses by weight."
  },
  {
    "id": "aemt-apap-scn-002",
    "scope": ["AEMT"],
    "medicationId": "aemt-apap-001",
    "medication": "Acetaminophen",
    "questionType": "multiple-choice",
    "stem": "A patient reports taking acetaminophen every 4 hours today for pain. Why is this information important?",
    "choices": [
      "It increases bleeding risk",
      "It may indicate toxic cumulative dosing",
      "It causes renal failure",
      "It prevents NSAID use"
    ],
    "correctAnswer": "It may indicate toxic cumulative dosing",
    "rationale": "Excess total daily dosing increases risk of liver injury.",
    "clinicalPearl": "Ask about all sources of acetaminophen."
  },

  {
    "id": "aemt-ibu-scn-001",
    "scope": ["AEMT"],
    "medicationId": "aemt-ibu-001",
    "medication": "Ibuprofen",
    "questionType": "multiple-choice",
    "stem": "A dehydrated patient with fever requests ibuprofen. Which concern is most relevant?",
    "choices": [
      "Respiratory depression",
      "Renal perfusion reduction",
      "Hypoglycemia",
      "Sedation"
    ],
    "correctAnswer": "Renal perfusion reduction",
    "rationale": "NSAIDs may worsen renal blood flow, especially when dehydrated.",
    "clinicalPearl": "Hydration status matters with NSAIDs."
  },

  {
    "id": "aemt-char-scn-001",
    "scope": ["AEMT"],
    "medicationId": "aemt-char-001",
    "medication": "Activated Charcoal",
    "questionType": "multiple-choice",
    "stem": "A patient ingested an unknown quantity of pills 30 minutes ago and is alert with intact gag reflex. What is the best next step?",
    "choices": [
      "Administer activated charcoal",
      "Induce vomiting",
      "Administer oral glucose",
      "Delay treatment until hospital arrival"
    ],
    "correctAnswer": "Administer activated charcoal",
    "rationale": "Early administration can reduce toxin absorption.",
    "clinicalPearl": "Time and airway determine charcoal use."
  },
  {
    "id": "aemt-char-scn-002",
    "scope": ["AEMT"],
    "medicationId": "aemt-char-001",
    "medication": "Activated Charcoal",
    "questionType": "multiple-choice",
    "stem": "Which finding would immediately contraindicate activated charcoal administration?",
    "choices": [
      "Nausea",
      "History of overdose",
      "Vomiting blood",
      "Decreased level of consciousness"
    ],
    "correctAnswer": "Decreased level of consciousness",
    "rationale": "Unprotected airway creates high aspiration risk.",
    "clinicalPearl": "Airway always comes first."
  },

  {
    "id": "aemt-duoneb-scn-001",
    "scope": ["AEMT"],
    "medicationId": "aemt-duoneb-001",
    "medication": "Albuterol / Ipratropium (DuoNeb)",
    "questionType": "multiple-choice",
    "stem": "A patient with COPD has wheezing, increased work of breathing, and SpO₂ of 89%. Which treatment is most appropriate?",
    "choices": [
      "CPAP only",
      "DuoNeb via nebulizer",
      "Naloxone",
      "Normal saline bolus"
    ],
    "correctAnswer": "DuoNeb via nebulizer",
    "rationale": "Bronchospasm in COPD responds to combined bronchodilators.",
    "clinicalPearl": "Treat bronchospasm early to prevent fatigue."
  },
  {
    "id": "aemt-duoneb-scn-002",
    "scope": ["AEMT"],
    "medicationId": "aemt-duoneb-001",
    "medication": "Albuterol / Ipratropium (DuoNeb)",
    "questionType": "multiple-choice",
    "stem": "After a DuoNeb treatment, which reassessment finding indicates improvement?",
    "choices": [
      "Increased heart rate",
      "Reduced wheezing and accessory muscle use",
      "Increased anxiety",
      "Lower blood pressure"
    ],
    "correctAnswer": "Reduced wheezing and accessory muscle use",
    "rationale": "Improved airflow reduces work of breathing.",
    "clinicalPearl": "Look at the patient, not just the monitor."
  },

  {
    "id": "aemt-glucose-scn-001",
    "scope": ["AEMT"],
    "medicationId": "aemt-glucose-oral-001",
    "medication": "Oral Glucose",
    "questionType": "multiple-choice",
    "stem": "A diabetic patient is confused but able to follow commands and swallow. Blood glucose is 54 mg/dL. What is the best treatment?",
    "choices": [
      "IV dextrose",
      "Oral glucose",
      "Naloxone",
      "Normal saline"
    ],
    "correctAnswer": "Oral glucose",
    "rationale": "Oral glucose is appropriate when airway and swallowing are intact.",
    "clinicalPearl": "Match treatment to mental status."
  },

  {
    "id": "aemt-nalox-scn-001",
    "scope": ["AEMT"],
    "medicationId": "aemt-nalox-001",
    "medication": "Naloxone",
    "questionType": "multiple-choice",
    "stem": "A patient has pinpoint pupils, RR of 6, and shallow breathing. What is the primary indication for naloxone?",
    "choices": [
      "Altered mental status",
      "Hypotension",
      "Respiratory depression",
      "Bradycardia"
    ],
    "correctAnswer": "Respiratory depression",
    "rationale": "Naloxone is indicated to reverse opioid-induced respiratory failure.",
    "clinicalPearl": "Breathing is the priority."
  },
  {
    "id": "aemt-nalox-scn-002",
    "scope": ["AEMT"],
    "medicationId": "aemt-nalox-001",
    "medication": "Naloxone",
    "questionType": "multiple-choice",
    "stem": "After naloxone administration, the patient becomes alert and combative. What is the most appropriate action?",
    "choices": [
      "Administer additional naloxone",
      "Physically restrain immediately",
      "Ensure scene safety and continue monitoring",
      "Administer acetaminophen"
    ],
    "correctAnswer": "Ensure scene safety and continue monitoring",
    "rationale": "Acute withdrawal can cause agitation; safety and monitoring are key.",
    "clinicalPearl": "Naloxone can change behavior rapidly."
  }
]


